Article

DNMT3A/TET2/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational study

2023-09-06

Abstract excerpt

<h4>Background: </h4> Polycythemia vera (PV) patients are classified as being of high or low thrombotic risk based on age>60 years and prior history of thrombosis. Despite adherence to treatment recommendations, vascular events remain frequent, even in younger patients, leading us to question whether thrombotic risk stratification could be improved. We previously reported an association between thrombotic events a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4b120f40-90a3-5e16-9bb7-30d5e207fd0c
DOI: 10.21203/rs.3.rs-3318385/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DNMT3A/TET2/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational studyDOI 10.21203/rs.3.rs-3318385/v1Read

DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study.Semantic proximity Read

Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 MutationsSemantic proximity Read

Development and validation of a multiple factor-based prognostic score system of thrombosis in polycythemia vera (MFPS-PV)Semantic proximity Read

Thrombosis-Driven Disease Progression in JAK2-Mutant Polycythemia Vera and Essential Thrombocythemia: Reassessing Risk-Based Management.Semantic proximity Read

[Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms].Semantic proximity Read

ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.Semantic proximity Read

[Vascular complications of essential thrombocythemia].Semantic proximity Read

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.Semantic proximity Read

Prognostic risk model for patients with high-risk polycythemia vera and essential thrombocythemia.Semantic proximity Read

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.Semantic proximity Read

[Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model].Semantic proximity Read

It is time to change thrombosis risk assessment for PV and ET?Semantic proximity Read